RMC-7977 Mechanism of Action: RAS Inhibition in Pancreatic Ductal Cell Research

RMC-7977 MOA:Targeting RAS/MAPK Pathway for Pancreatic Ductal Adenocarcinoma

🎯 check RMC-7977 product page

RMC-7977 is a potent pan-RAS(ON) inhibitor. It blocks RAS, inhibiting cell viability, thereby affecting the MAPK pathway.

Primary Applications and Mechanism of Action